This company is a reverse logistics specialist purchasing excess, closeout, and discontinued inventory directly from brand owners for cash. The business operates through multiple channels to resell inventory via wholesale, e-commerce, and retail outlets, allowing clients to recover value without disrupting their existing sales channels.
Key Categories: Health & Beauty, Home Goods, Electronics, Grocery, Lawn & Garden, Toys, Hardware, Automotive.
Rationale for Acquisition
– Leverages strong buyer and supplier networks across nationwide market opportunities.
– Expanding e-commerce presence through an owned distribution subsidiary and retail outlet.
– Positioned to scale with minimal capex amid growing demand for liquidation efficiency.
Investment Highlights
– Multi-channel distribution across wholesale, retail, and e-commerce resale.
– Asset-light model with recurring supplier relationships.
– Rapid cash purchase model—offers made within one business day.
– Positioned in the growing circular economy and resale markets.
– Scalable platform with consistent throughput and margin expansion opportunities.
– Inventory balance of $850K will transfer with the business
Fill out our business inquiry form and we’ll reach out to discuss your details.
Mark leads Viking Mergers & Acquisitions for the Washington, DC-metro area supporting business owners with sell-side and valuation advisory services. With a vast experience in corporate finance across domestic and international markets, Mark brings over 25 years of experience providing valuation, finance and transaction advisory services.
Before launching Viking, Mark was with Bank of America, focused on the healthcare sector specializing in commercial and investment banking services for middle market clients. Prior to that, he led the Valuation and Business Analytics Group at BDO in the D.C. metro area, overseeing business combination analyses, goodwill impairment assessments, and other bespoke valuation engagements.
Earlier in his career, Mark held leadership roles in the Transaction Advisory, Valuation, and Business Modeling groups at EY and PwC, where he advised on a diverse range of transactions across various industries and deal sizes. His career began in the biotech sector, where he led teams in genetic mapping and protein purification.
Mark holds anMBA in Finance and International Management from the Kogod School of Business (American University) and a bachelor’s degree in Biology from the University of Maryland.
